Symmetric
  • TRAINING COURSES
  • IN-HOUSE TRAINING
  • CLIENTS
  • TRAINERS
  • BLOG
  • ABOUT US
  • CONTACT

Join Symmetric Newsletter

Sign up today so you don't miss any special offers, new events and pharma breaking news.

TOP 3 Pharma & Biotech Worldwide News Once a Month

Interviews With Industry Professionals Once Every Three Months

Regular Event Calendar & Special Offers Once Every Six Months

Symmetric s.r.o.

Mliekarenska 7

82109 Bratislava

Slovak Republic

ID: 47 068 124

VAT No: SK2023741973

Office: +421 948 262 346

LinkedIn

Booking & Support

Phone (EU):+421 948 262 346 (9:00 - 17:00 CET)

Phone (US):+1 857 392 2714 (9:00 - 16:00 ET)

Email:info@symmetric.events

A real member of our team answers our chat

Terms & ConditionsPrivacy PolicyChange Your Cookie Consent

© 2026 Symmetric s.r.o.

Drug-Device Combination Products: Quality & Regulatory Requirements
Medical Devices
Combination Products

Drug-Device Combination Products: Quality & Regulatory Requirements

Date to be announced

Contact us for more info
Price available after dates are announced

TRAINING TIMES

  • TBDVienna
  • TBDLondon
  • TBDNew York
  • TBDLos Angeles
Online Training

WHY SHOULD YOU ATTEND?

Understand the regulatory pathway

Learn how to navigate regulatory expectations for drug-device combinations

Learn to integrate design control

Get clarity on how to integrate risk analysis, and GSPR requirements into your product development

Build a compliant control strategy

Learn to create a clear strategy that aligns clinical, regulatory, and quality components

Avoid costly delays and rejections

Learn how to anticipate regulatory expectations early and structure your submission to prevent setbacks during review.


OUR ONLINE TRAINING EXPERIENCE INCLUDE

Two days of expert-led Zoom sessions packed with discussions, Q&As, and real-world scenarios.

All slides, tools, and supporting materials available in our CLIENT ZONE before, during, and after the course.

Receive a digital certificate (also Linkedin-ready) that verifies your skills in strategic trial planning.


LEARNING OBJECTIVES

Learning Objective

Understand global requirements for combination products

Learn how to navigate both drug and device regulations, including FDA, EMA, and Notified Body pathways

Learning Objective

Align with regulators and internal teams

Discover how to justify design choices, risk strategies, and documentation that hold up under scrutiny

Learning Objective

Build a compliant control strategy

Develop an integrated plan covering clinical, quality, and design control elements to support product approval

Learning Objective

Avoid costly regulatory pitfalls

Spot potential compliance issues early and learn how to prevent delays during review and approval


WHO IS THIS TRAINING FOR?

Designed for professionals who want to enhance their expertise and advance their careers

Regulatory Affairs

Quality Assurance and Control

Device Engineering & Manufacturing

Research & Development


KEY TOPICS

Understand drug-device and device-drug regulatory pathway
Apply design control and risk management principles to combination products
Ensure labeling, GSPR, and QMS alignment
Plan post-market surveillance and manage ongoing regulatory responsibilities

TRAINER

James Pink

James Pink

Health Sciences and Medical Devices Consultant

James Pink has over 25 years of experience in the medical devices industry including 10 years as a healthcare technology expert and lead auditor for a leading European notified body. He began his career as a product designer in the oil tools industry moving into medical physics and clinical engineering at the Royal Hallamshire Hospital in Sheffield, UK. His industry experience includes managing product development and quality assuranceprograms for active and non-active implantable and combination products. James is a contributor to several medical device standards committees including ISO13485, ISO 14971 and various product-related standards.

Learn More →

Sneak peek

Sneak Peek

Take a sneak peek at the trainer's presentation.

View PDF →